ACCESSWIRE

Ovation Science Inc.

Share
Ovation Science Announces Expanded Distribution of DermSafe Hand Sanitizer

On-going Pandemic Has Raised Importance for Employers to Implement Preventive Measures

VANCOUVER, BC and LAS VEGAS, NV / ACCESSWIRE / August 12, 2021 / (CSE:OVAT)(OTCQB:OVATF) - Ovation Science Inc. ("Ovation" or the "Company") is pleased to announce it has secured Pivot Protection Resource as a new national distributor for its non-alcohol hand sanitizer lotion, DermSafe®. Pivot Protection will be targeting their extensive business contacts across Canada. This Canadian PPE company, with vast experience in B2B including the healthcare industry, is committed to providing innovative products that are designed to aid in the protection of people in their work environment. With the pandemic continuing to spread due to the Delta variant, employers are looking for proven solutions to help employees feel safe about returning to work.

"There are many government campaigns and initiatives that are spreading awareness about the importance of preventive measures against the coronavirus as everyone returns to work," said Lyle Mills, President of Pivot Protection Resource. "We felt there was a great need for a non-alcohol hand sanitizer and one that had the science to back its effectiveness. We were therefore excited to learn about the unique benefits of DermSafe and look forward to making it available to our contacts across Canada. Pivot Protection Resource is committed to and excited about representing products that will truly make a difference."

"According to a recent New York Times article, on average we touch our face about 16 times per hour, and each time this exposes us to germs including the Delta variant," said Terry Howlett, President of Ovation Science. “The CDC (Center for Disease Control and Prevention) recommends we wash our hands for at least 20 seconds with soap or to use a hand sanitizer. People however are under the impression that alcohol hand sanitizers are all the same and will protect them against this virus. The fact is that many products do not have the recommended alcohol level of 70%. As well, people often do not use enough alcohol hand sanitizer for it to be effective. A whole ‘palm full' is the recommended amount or 3 ml., making a 60 ml hand sanitizer bottle last only 20 applications.” (Source: The New York Times: "The pandemic habit we should not break"; July 12, 2021). He continued, "DermSafe is different. It has no alcohol; it is proven effective against a host of germs and it requires only 1 ml per application so a 60 ml bottle lasts a whole month (2 applications/day). It is the perfect solution for employers looking for effective solutions when bringing their staff back safely to work."

DermSafe protects your hands against germs without the drying effects of alcohol. DermSafe uses 4% chlorhexidine gluconate (CHG), an ingredient used for over five decades in hospital scrub-up rooms. CHG has demonstrated long-term persistence in its ability to kill both gram-negative and gram-positive bacteria and viruses. Additionally, DermSafe is made with Invisicare® skin technology that helps the product bind to the skin, DermSafe has also been tested against a host of infectious germs, including the human coronavirus (Beta Coronavirus strain OC43, a surrogate for SARS-CoV-2); the virus that causes COVID-19 which was previously announced. The independent tests that were conducted showed a 99.97% reduction in the virus at 2 time points. Also, the Company previously announced that DermSafe is the only hand sanitizer that is a recipient of the Canadian Dermatology Review Panel's "Seal of Approval". This is an independent review by Canadian dermatologists.

The pandemic has raised awareness about the importance of personal hygiene including washing your hands frequently and using a hand sanitizer. This has led to increased sales worldwide, with hand sanitizer sales predicted to surpass USD 6.4 billion by 2027 according to Global Market Insights Inc.

To order from Pivot Protection visit https://pivotprotection.com/

For information about DermSafe and how to order visit https://dermsafe.com

For information about Ovation Science visit https://ovationscience.com.

Statements have not been evaluated by the Food and Drug Administration or Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease.

About Ovation Science Inc.

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products including its unique DermSafe® hand sanitizer and secondly its CBD/THC cannabis formulations including ARLO CBD Beauty and InVibe® MD ("health & wellness" line); all made with its patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin. With over twenty years of topical and transdermal drug delivery experience in the pharmaceutical market, Ovation's management and science team have created a unique pipeline of over twenty-five patent-protected medical / wellness topical and transdermal products along with a line of anti-aging / beauty formulas. Ovation earns revenues from licensing and development fees, royalties, the sale of Invisicare to its licensees along with revenue from its own product sales. Ovation has its head office in Vancouver, BC Canada and its laboratory and operations in Las Vegas, Nevada, USA. Ovation trades on the CSE under the symbol OVAT and in the USA on the OTC Markets under the symbol OVATF. Visit our website www.ovationscience.com for more information.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular there is no assurance that the Company's DermSafe product will have increased sales,and that any additional exposure will result in sales. Although DermSafe has been tested against other envelope viruses there is no assurance that it will kill or be as effective against COVID-19 or the Delta variant. In addition, there is no assurance the Company's level of sales will continue or will not be negatively impacted by increased competition and recovery from the coronavirus pandemic. There is also no evidence it works better than alcohol. Other examples of the assumptions underlying the forward-looking statements contained herein include, but are not limited to those related to: strategies, potential sales, distribution and manufacturing of the Company's product as well as its effectiveness against COVID-19, the Company's ability to receive regulatory approval outside of Canada. There are no guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.'s control. Accordingly, readers should not place undue reliance on the forward-looking information. Ovation disclaims any obligation to revise or update any such forward-looking information to reflect future results, events or circumstances, except as required by law.

Statements have not been evaluated by the Food and Drug Administration or Health Canada. These products are not intended to diagnose, treat, cure, or prevent any disease. Ovation does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

INVESTOR RELATIONS:
Kin Communications: ovat@kincommunications.com
Phone: 604-684-6730 or Toll Free at 866-684-6730

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:
Doreen McMorran: doreen@ovationscience.com
Phone: 604-283-0903 ext. 4

SOURCE: Ovation Science Inc.



View source version on accesswire.com:
https://www.accesswire.com/659389/Ovation-Science-Announces-Expanded-Distribution-of-DermSafe-Hand-Sanitizer

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESSWIRE

DK

Subscribe to releases from ACCESSWIRE

Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESSWIRE

Stoof International GmbH Presents Specially Protected Vehicles and Innovative Security Concepts at Security Essen 202417.9.2024 09:15:00 CEST | Press release

BRUSSELS, BELGIUM / ACCESSWIRE / September 17, 2024 / STOOF International GmbH, a leading global supplier of armoured vehicles and security equipment, is pleased to announce its participation in Security Essen 2024. The trade fair, which will take place in Essen from 17 to 20 September 2024, is one of the world's most important platforms for security and fire protection solutions. As a high-performance company in the security industry, STOOF International GmbH offers a wide range of specially protected off-road vehicles, armoured limousines, cash and valuables transporters and trucks. At Security Essen, the latest products and technologies will be presented that have been specially developed to meet the growing demands in the field of security. Visitors to the trade fair will have the opportunity to find out first-hand about the advanced solutions from STOOF International GmbH and experience the exceptional quality and performance of its products. More than ever, security has become a

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management17.9.2024 08:30:00 CEST | Press release

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma TORONTO, ON / ACCESSWIRE / September 17, 2024 / Ripple Therapeutics today announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a next generation, fully biodegradable, sustained release drug delivery intracameral implant with repeat dosing capabilities to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). This collaboration leverages AbbVie's expertise in eye care and Ripple's innovative drug delivery platform. Ripple's patented technology platform is based on a discovery that drugs can be engineered into controlled release pharmaceuticals without the use of polymers or excipients. These proprietary prodrugs undergo surface erosion to give zero order release kinetics and are highly customizable to

Sidoti Events, LLC's Virtual September Small-Cap Conference17.9.2024 08:00:00 CEST | Press release

NEW YORK, NY / ACCESSWIRE / September 17, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and Thursday, September 18-19, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links. Presentation Schedule *All Times EDT Wednesday, September 18, 2024 (Day 1) 8:30-9:00 MtronPTI (MPTI) The Gorman-Rupp Company (GRC) Lilium (LILM) ***** 9:15-9:45 The LGL Group, Inc. (LGL) Natural Gas Services Group (NGS) Harvard Bioscience (HBIO) Lifetime Brands, Inc. (LCUT) 10:00-10:30 Daktronics (DAKT) Arcosa, Inc (ACA) STRATTEC Security Corporation (STRT) Luxfer (LXFR) 10:45-11:15 Genco Shipping & Trading (GNK) Tecnoglass (TGLS) Koil Energy Solutions (KLNG) Charles River Associates (CRAI) 11:30-12:00 Insight Enterprises (NSIT) AZZ Inc (AZZ) Topaz Energy Corp (TPZ) Information Services Corporat

Sidoti Events, LLC's Virtual September Small-Cap Conference17.9.2024 08:00:00 CEST | Press release

NEW YORK, NY / ACCESSWIRE / September 17, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and Thursday, September 18-19, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links. Presentation Schedule *All Times EDT Wednesday, September 18, 2024 (Day 1) 8:30-9:00 MtronPTI (MPTI) The Gorman-Rupp Company (GRC) Lilium (LILM) ***** 9:15-9:45 The LGL Group, Inc. (LGL) Natural Gas Services Group (NGS) Harvard Bioscience (HBIO) Lifetime Brands, Inc. (LCUT) 10:00-10:30 Daktronics (DAKT) Arcosa, Inc (ACA) STRATTEC Security Corporation (STRT) Luxfer (LXFR) 10:45-11:15 Genco Shipping & Trading (GNK) Tecnoglass (TGLS) Koil Energy Solutions (KLNG) Charles River Associates (CRAI) 11:30-12:00 Insight Enterprises (NSIT) AZZ Inc (AZZ) Topaz Energy Corp (TPZ) Information Services Corporat

Sidoti Events, LLC's Virtual September Small-Cap Conference17.9.2024 08:00:00 CEST | Press release

NEW YORK, NY / ACCESSWIRE / September 17, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and Thursday, September 18-19, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links. Presentation Schedule *All Times EDT Wednesday, September 18, 2024 (Day 1) 8:30-9:00 MtronPTI (MPTI) The Gorman-Rupp Company (GRC) Lilium (LILM) ***** 9:15-9:45 The LGL Group, Inc. (LGL) Natural Gas Services Group (NGS) Harvard Bioscience (HBIO) Lifetime Brands, Inc. (LCUT) 10:00-10:30 Daktronics (DAKT) Arcosa, Inc (ACA) STRATTEC Security Corporation (STRT) Luxfer (LXFR) 10:45-11:15 Genco Shipping & Trading (GNK) Tecnoglass (TGLS) Koil Energy Solutions (KLNG) Charles River Associates (CRAI) 11:30-12:00 Insight Enterprises (NSIT) AZZ Inc (AZZ) Topaz Energy Corp (TPZ) Information Services Corporat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye